By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences said that its LabChip Dx instrument has received the CE IVD Mark, making the instrument available for use with clinical patient samples in Europe. The instrument was developed in collaboration with South Korean molecular diagnostics firm Seegene and runs assays developed by Seegene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.